Ulcerative Colitis Clinical Trials in Phoenix

Showing 361-380 of 587 trials

Cobiprostone Prevention of NSAID-induced Gastroduodenal Injury

NCT00597818

The primary purpose of this study is to determine the efficacy and safety of three dose levels of cobiprostone as compared to placebo in OA/RA patients treated with an NSAID for 20 months.

NSAID-induced Gastroduodenal InjuryUlcersRheumatoid Arthritis+1 more

Sucampo Pharma Americas, LLC121 participantsStarted Aug 2007

Phoenix, Arizona, United States • Chula Vista, California, United States • Loma Linda, California, United States +16 more locations

COMPLETEDPhase 2< 1 mile

Study To Assess Efficacy and Safety of Oglemilast in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT00671073

This study will assess the safety and efficacy of a range of oglemilast doses. The study will be 14 weeks in duration. All patients meeting the eligibility criteria will be randomized to one of three doses of oglemilast or placebo.

Pulmonary Disease, Chronic Obstructive

Forest Laboratories427 participantsStarted May 2008

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Tucson, Arizona, United States +44 more locations

Cobiprostone Prevention of NSAID-induced Gastroduodenal Injury

Study To Assess Efficacy and Safety of Oglemilast in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Ulcerative Colitis Trials in Other Cities

An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

Glycemic Response of Bean-and-rice Meals in Type 2 Diabetes Mellitus

Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle Glaucoma

Propranolol Hydrochloride and Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Benralizumab Efficacy in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation History

Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD

Study Assessing Safety and Efficacy of PG324 Ophthalmic Solution in Patients With Elevated Intraocular Pressure

New Tablet Formulation and Dosing Regimen of Balsalazide Disodium in Mildly to Moderately Active Ulcerative Colitis

Long-Term Safety and Tolerability of Mesalamine Pellets in Participants With Ulcerative Colitis in Remission

Soft Contacts Observation of Risk and Education (SCORE)

Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer

Proof of Concept Study to Assess Activity and Safety of SMT C1100 (Ezutromid) in Boys With Duchenne Muscular Dystrophy (DMD)

Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy

Trastuzumab in Treating Patients With Locally Advanced or Metastatic Gallbladder Cancer or Bile Duct Cancer That Cannot Be Removed by Surgery

Macrolide Azithromycin to Prevent Rapid Worsening of Symptoms Associated With Chronic Obstructive Pulmonary Disease

An Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)

Comparison of SomnaPatch With Polysomnography in Sleep Disordered Breathing

A Study of Abemaciclib (LY2835219) Alone or in Combination With Other Agents in Participants With Previously Treated Pancreatic Ductal Adenocarcinoma

Other Conditions in Phoenix